These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3584079)

  • 1. Injection site leakage of depot neuroleptics: intramuscular versus subcutaneous injection.
    Glazer WM; Maynard C; Berkman CS
    J Clin Psychiatry; 1987 Jun; 48(6):237-9. PubMed ID: 3584079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant greater loss of medication from the injection site when fluphenazine (Prolixin) decanoate was injected intramuscularly as contrasted with subcutaneously.
    Gelenberg AJ
    J Clin Psychiatry; 1987 Oct; 48(10):425. PubMed ID: 3667545
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug monitoring at an Australia depot phenothiazine clinic.
    Marriott P; Hiep A
    J Clin Psychiatry; 1978 Mar; 39(3):206-12. PubMed ID: 580271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
    Jayaram G; Coyle J; Tune L
    J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of fluphenazine decanoate. Effects of site of injection, massage and muscle activity.
    Soni SD; Wiles D; Schiff AA; Bamrah JS
    Br J Psychiatry; 1988 Sep; 153():382-4. PubMed ID: 3250675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of fluphenazine decanoate in psychiatric therapy. Multicenter study in 1095 patients preselected for long-acting neuroleptic treatment].
    Bogliolo C
    Minerva Psichiatr; 1986; 27(1):1-18. PubMed ID: 3713474
    [No Abstract]   [Full Text] [Related]  

  • 8. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous tissue thickness in children with type 1 diabetes.
    Shin H; Kim MJ
    J Adv Nurs; 2006 Apr; 54(1):29-34. PubMed ID: 16553688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluphenazine enanthate for the difficult psychotic patient.
    Stewart AR; Lavallee B
    Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.
    Luo JP; Hubbard JW; Midha KK
    Pharm Res; 1997 Aug; 14(8):1079-84. PubMed ID: 9279892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of extremely low doses of fluphenazine decanoate.
    Geller J
    Am J Psychiatry; 1990 May; 147(5):672. PubMed ID: 2327499
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of fluphenazine decanoate (Modecate)depot therapy in outpatient schizophrenics-a retrospective study.
    Tan CT; Ong TC; Chee KT
    Singapore Med J; 1981 Aug; 22(4):214-8. PubMed ID: 7323829
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
    Polácek J
    Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with depot neuroleptics in ambulatory practice.
    Fiolet J
    Acta Psychiatr Belg; 1981; 81(2):182-8. PubMed ID: 6117188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
    Jouen F; Verité P; André D; Colonna L; Boucly P
    Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate.
    Umino M; Kobayashi R; Nisijima K; Suda S
    Prim Care Companion CNS Disord; 2017 Sep; 19(5):. PubMed ID: 28972705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.